Exposure to rosiglitazone and fluoxetine in the first trimester of pregnancy [3]

Diabetes Care

Volumn 29, Issue 9, 2006, Pages 2176-

  Choi, June Seek ^a   Han, Jung Yeol ^a,c   Ahn, Hyun Kyong ^a   Shin, Joong Sik ^a   Yang, Jae Hyug ^a   Koong, Mi Kyoung ^a   Nava Ocampo, Alejandro A ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; AMITRIPTYLINE; ATORVASTATIN; CARBAMAZEPINE; CHLORDIAZEPOXIDE; FLUOXETINE; GLIBENCLAMIDE; GLICLAZIDE; GLUCOSE; HEMOGLOBIN A1C; HYDROCHLOROTHIAZIDE; INSULIN; METFORMIN; PIPENZOLATE BROMIDE; ROSIGLITAZONE; SPIRONOLACTONE; THIORIDAZINE;

ADULT; BODY MASS; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRENATAL DRUG EXPOSURE; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; FLUOXETINE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; SEROTONIN UPTAKE INHIBITORS; THIAZOLIDINEDIONES;

EID: 33845348640     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1214     Document Type: Letter

References (2)

1. Yaris F, Yaris E, Kadioglu M, Ulku C, Kesim M, Kalyoncu NI: Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman. Reprod Toxicol 18:619-621, 2004
2. Kalyoncu NI, Yaris F, Ulku C, Kadioglu M, Kesim M, Unsal M, Dikici M, Yaris E: A case of rosiglitazone exposure in the second trimester of pregnancy. Reprod Toxicol 19:563-564, 2005